BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L
991 results:

  • 1. FOXO3a deregulation in uterine smooth muscle tumors.
    de Almeida TG; Ricci AR; Dos Anjos LG; Soares Junior JM; Maciel GAR; Baracat EC; Carvalho KC
    Clinics (Sao Paulo); 2024; 79():100350. PubMed ID: 38636197
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Leiomyosarcoma of sphenoid sinus- A rare tumor at an unusual site.
    Rana D; Gautam R; Mallya V; Khurana N; Mehar R; Singh K
    J Cancer Res Ther; 2024 Jan; 20(1):485-487. PubMed ID: 38554372
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Subcutaneous Leiomyosarcoma Of Supra-Pubic Region Managed With Wide Local Excision And Total Penectomy.
    Nazim SM; Nusrat A; Bashir A
    J Ayub Med Coll Abbottabad; 2023; 35(3):490-492. PubMed ID: 38404100
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Conjunctival leiomyosarcoma: A clinico-pathological study with in deep molecular characterization.
    Santoro A; Angelico G; Mulè A; Minucci A; Giannuzzi F; Sammarco MG; Pagliara MM; Blasi MA
    Pathol Res Pract; 2024 Mar; 255():155182. PubMed ID: 38335782
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Regional variations in the management of primary hyperparathyroidism in Sweden: population-based case-control study.
    Thorsteinsson D; Granath F; Bränström R; Koman A; Zedenius J; Nilsson IL
    BJS Open; 2024 Jan; 8(1):. PubMed ID: 38323883
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel nomogram and recursive partitioning analysis for predicting cancer-specific survival of patients with subcutaneous leiomyosarcoma.
    Ji Q; Hu H; Li S; Tang J
    Sci Rep; 2024 Feb; 14(1):2861. PubMed ID: 38311615
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue sarcomas: Clinical Outcomes and Biological Correlates.
    Haddox CL; Nathenson MJ; Mazzola E; Lin JR; Baginska J; Nau A; Weirather JL; Choy E; Marino-Enriquez A; Morgan JA; Cote GM; Merriam P; Wagner AJ; Sorger PK; Santagata S; George S
    Clin Cancer Res; 2024 Apr; 30(7):1281-1292. PubMed ID: 38236580
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Surgery and stereotactic radiosurgery for spinal leiomyosarcoma: a single-institution retrospective series and systematic review.
    Zamarud A; Marianayagam NJ; Sekar V; Testa S; Park DJ; Yener U; McCleary TL; Yoo KH; Emrich S; Tayag A; Ustrzynski L; Pollom E; Soltys S; Wang L; Charville G; Ganjoo K; Chang SD; Meola A
    J Neurosurg Spine; 2024 Apr; 40(4):485-497. PubMed ID: 38157539
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
    Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
    Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Survivin-Sodium Iodide Symporter Reporter as a Non-Invasive Diagnostic Marker to Differentiate Uterine Leiomyosarcoma from Leiomyoma.
    Garcia N; Ulin M; Yang Q; Ali M; Bosland MC; Zeng W; Chen L; Al-Hendy A
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132150
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary cutaneous SMARCA4-deficient undifferentiated malignant neoplasm: A rare case report and literature review.
    Gumusgoz E; Graham BS; Hosler GA
    J Cutan Pathol; 2024 Apr; 51(4):262-266. PubMed ID: 38124373
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. POTENTIAL LIFE PROGNOSTIC MARKER FOR MESENCHYMAL TUMOR RESEMBLING UTERINE LEIOMYOSARCOMA.
    Nishikawa S; Hayashi T; Uzaki T; Yaegashi N; Abiko K; Konishi I
    Georgian Med News; 2023 Oct; (343):119-126. PubMed ID: 38096528
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Single protein encapsulated SN38 for tumor-targeting treatment.
    Yu C; Huang F; Wang K; Liu M; Chow WA; Ling X; Li F; Causey JL; Huang X; Cook-Wiens G; Cui X
    J Transl Med; 2023 Dec; 21(1):897. PubMed ID: 38072965
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Acantholytic squamous cell carcinoma mimicking epithelioid angiosarcoma: A diagnostic challenge by cytology.
    Taweevisit M; Sutthiruangwong P; Thorner PS
    Diagn Cytopathol; 2024 Mar; 52(3):E76-E79. PubMed ID: 38069674
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Smooth muscle tumours of the uterus: MR imaging malignant predictive features-a 12-year analysis in a referral hospital in Portugal.
    Freitas P; Resende-Neves T; Lameira P; Costa M; Dias P; Filipe J; Ferreira J; Félix A; Cunha TM
    Arch Gynecol Obstet; 2024 Apr; 309(4):1551-1560. PubMed ID: 38055011
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A human-interpretable machine learning pipeline based on ultrasound to support leiomyosarcoma diagnosis.
    Lombardi A; Arezzo F; Di Sciascio E; Ardito C; Mongelli M; Di Lillo N; Fascilla FD; Silvestris E; Kardhashi A; Putino C; Cazzolla A; Loizzi V; Cazzato G; Cormio G; Di Noia T
    Artif Intell Med; 2023 Dec; 146():102697. PubMed ID: 38042596
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic value of mitotic count in leiomyosarcoma: A comprehensive monocentric retrospective study.
    Grimaudo MS; Renne SL; Colombo P; Giordano L; Gennaro N; Laffi A; Cariboni U; Cananzi FCM; Ruspi L; Santoro A; Bertuzzi AF
    Hum Pathol; 2024 Jan; 143():17-23. PubMed ID: 38000682
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. PD-1 Inhibition in metastatic high tumour mutational burden (TMB) leiomyosarcoma with clinicopathological correlates.
    Pandita D; Dave M; Schulte B
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37977843
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prediction of 5-year survival in soft tissue leiomyosarcoma using a machine learning model algorithm.
    Kamalapathy PN; Gonzalez MR; de Groot TM; Ramkumar D; Raskin KA; Ashkani-Esfahani S; Lozano-Calderón SA
    J Surg Oncol; 2024 Mar; 129(3):531-536. PubMed ID: 37974529
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (lms).
    Movva S; Matloob S; Handorf EA; Choy E; Merriam P; Flieder DB; Cai KQ; Zhou Y; Tetzlaff ED; Pagan C; Barker E; Veggeberg R; Zumpano D; Rink L; von Mehren M; George S
    Clin Cancer Res; 2024 Jan; 30(2):315-322. PubMed ID: 37967116
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 50.